Clinical Trial Update: Cortical Excitability Changes Induced by Retigabine: a Transcranial Magnetic Stimulation Study [Phase 3]

View source ↗

Summary

Phase 3 study results examining how retigabine (ezogabine) affects cortical excitability as measured by transcranial magnetic stimulation in epilepsy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy

Drugs mentioned

• Potiga (ezogabine)

Snippet

Sponsor: University Hospital of Mont-Godinne | Conditions: Epilepsy | Phase 3 | Status: COMPLETED